Learn more about Peter Attia’s digital program
#32 – Siddhartha Mukherjee, M.D., Ph.D.: new frontiers in cancer therapy, medicine, and the writing process
“The fundamental rule that works for me is just to throw something at the world. The first line, the first experiment, the first idea, and then, keep at it.” —Siddhartha Mukherjee
#30 – Thomas Seyfried, Ph.D.: Controversial discussion—cancer as a mitochondrial metabolic disease?
“The standard of care should never have been written in granite. It should be flexible. If you have something else that comes along that might be better, you’d think there would be enthusiasm.” —Tom Seyfried
#10 – Matt Kaeberlein, Ph.D.: rapamycin and dogs — man’s best friends? — living longer, healthier lives and turning back the clock on aging and age-related diseases
“I believe that rigorously demonstrating that we can increase healthspan and lifespan in pet dogs will be a huge step toward gaining the support and credibility that the field needs.” —Matt Kaeberlein
#09 – David Sabatini, M.D., Ph.D.: rapamycin and the discovery of mTOR — the nexus of aging and longevity?
“It’s the happenstance of science that makes it interesting.” —David Sabatini
#05 – Dom D’Agostino, Ph.D.: ketosis, n=1, exogenous ketones, HBOT, seizures, and cancer
“I immerse myself in what I’m doing…that’s how we learn.” —Dom D’Agostino
Fat, cancer, discomfort, and giving
This week we learned there’s often more to the story than the one you’re being told.
Lack of context may fuel spread of unintended consequences
A recent study on diet and prostate cancer suggests we need to be more careful communicating and interpreting information.
Is red meat killing us?
I wrote this post almost six years ago (March 21, 2012), but it’s the gift that keeps on giving.
Is there a way to exploit the metabolic quirk of cancer?
Can we starve the disease?
The War on Cancer
How are we faring in the War on Cancer?